3M TDD EMEA Business Manager
Telephone +44 (0) 15 09 613 660
Kirsty Gapp has a background in Molecular Biology and gained her PhD from the University of Warwick. She is currently the Global Business Team Leader for 3M’s Microneedle Platform and Business Manager for 3Ms Transdermal Drug Delivery Platform (Europe). Over the last 15 years Kirsty has held various technical and commercial roles within 3M Health Care with a focus on medical devices. She now works in 3M’s Drug Delivery Systems Division in the areas of transdermal and intradermal technology platforms.
3M Drug Delivery Systems (DDS) partners with global pharmaceutical and biotech companies to develop and manufacture pharmaceuticals using 3M’s inhalation or transdermal drug delivery technology including microneedles, to help get their product to market. With over 50 years experience 3M DDS offers both traditional & innovative technologies suitable for the biopharmaceutical & pharmaceutical sectors: solid & hollow Microneedle Systems, Pressurised Metered Dose Inhalers, Drug-in-Adhesive and Transdermal Patches.
Microneedle Drug Delivery: A Novel Delivery Platform for Small Molecules and Macromolecules
Please click to logos to go back to the agenda
School of Chemistry, Bangor University, Bangor, Gwynedd, LL57 2UW, UK
Direct Line: 0044 1248 383741 email: firstname.lastname@example.org